DF Dent & Co. Inc. cut its position in Stericycle, Inc. (NASDAQ:SRCL) by 59.6% during the first quarter, Holdings Channel reports. The firm owned 240,839 shares of the business services provider’s stock after selling 355,333 shares during the period. DF Dent & Co. Inc.’s holdings in Stericycle were worth $19,963,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Vanguard Group Inc. increased its position in Stericycle by 3.2% in the first quarter. Vanguard Group Inc. now owns 8,094,210 shares of the business services provider’s stock valued at $670,929,000 after buying an additional 251,061 shares in the last quarter. BlackRock Inc. increased its position in Stericycle by 3,492.3% in the first quarter. BlackRock Inc. now owns 5,089,580 shares of the business services provider’s stock valued at $421,877,000 after buying an additional 4,947,900 shares in the last quarter. FMR LLC increased its position in Stericycle by 8.2% in the first quarter. FMR LLC now owns 2,925,407 shares of the business services provider’s stock valued at $242,486,000 after buying an additional 221,262 shares in the last quarter. Fairpointe Capital LLC increased its position in Stericycle by 14.5% in the first quarter. Fairpointe Capital LLC now owns 2,391,424 shares of the business services provider’s stock valued at $198,225,000 after buying an additional 302,369 shares in the last quarter. Finally, Wells Fargo & Company MN increased its position in Stericycle by 25.5% in the first quarter. Wells Fargo & Company MN now owns 1,956,193 shares of the business services provider’s stock valued at $162,149,000 after buying an additional 398,076 shares in the last quarter. 96.51% of the stock is owned by hedge funds and other institutional investors.

Institutional Ownership by Quarter for Stericycle (NASDAQ:SRCL)

Shares of Stericycle, Inc. (NASDAQ:SRCL) opened at 76.88 on Monday. The stock’s 50 day moving average is $82.42 and its 200 day moving average is $80.72. The firm has a market cap of $6.56 billion, a P/E ratio of 40.06 and a beta of 0.15. Stericycle, Inc. has a 12 month low of $71.52 and a 12 month high of $107.74.

Stericycle (NASDAQ:SRCL) last posted its earnings results on Thursday, May 4th. The business services provider reported $1.09 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.05 by $0.04. Stericycle had a return on equity of 14.40% and a net margin of 5.23%. The firm had revenue of $892.40 million for the quarter, compared to analysts’ expectations of $874.34 million. During the same period in the previous year, the firm earned $1.11 earnings per share. The business’s revenue was up 2.1% compared to the same quarter last year. Equities research analysts expect that Stericycle, Inc. will post $4.63 EPS for the current year.

TRADEMARK VIOLATION NOTICE: “DF Dent & Co. Inc. Has $19.96 Million Stake in Stericycle, Inc. (SRCL)” was first posted by Daily Political and is the sole property of of Daily Political. If you are viewing this story on another site, it was copied illegally and reposted in violation of international copyright and trademark laws. The correct version of this story can be viewed at https://www.dailypolitical.com/2017/06/26/df-dent-co-inc-has-19-96-million-stake-in-stericycle-inc-srcl.html.

Several research analysts have recently issued reports on SRCL shares. Deutsche Bank AG lowered their price objective on Stericycle from $14.00 to $10.00 and set a “buy” rating for the company in a research note on Monday, May 15th. Jefferies Group LLC set a $108.00 price objective on Stericycle and gave the company a “buy” rating in a research note on Thursday, March 16th. Robert W. Baird downgraded Stericycle from a “neutral” rating to an “underperform” rating and lowered their price objective for the company from $74.00 to $73.00 in a research note on Friday, May 5th. Zacks Investment Research downgraded Stericycle from a “buy” rating to a “hold” rating in a research note on Tuesday, May 2nd. Finally, Goldman Sachs Group, Inc. (The) raised Stericycle from a “sell” rating to a “neutral” rating and upped their price objective for the company from $62.00 to $79.00 in a research note on Tuesday, March 7th. Three research analysts have rated the stock with a sell rating, six have given a hold rating and six have given a buy rating to the stock. The stock currently has an average rating of “Hold” and an average price target of $82.17.

Stericycle Company Profile

Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.

Want to see what other hedge funds are holding SRCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stericycle, Inc. (NASDAQ:SRCL).

Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with MarketBeat.com's FREE daily email newsletter.